Browsing Vanderbilt University Medical Center by Subject "OPEN-LABEL"
Now showing items 1-2 of 2
-
(Journal of Clinical Oncology, 2019-04-20)PURPOSE CheckMate 568 is an open-label phase II trial that evaluated the efficacy and safety of nivolumab plus low-dose ipilimumab as first-line treatment of advanced/metastatic non-small-cell lung cancer (NSCLC). We ...
-
(Blood Cancer Journal, 2019-03-29)This phase I dose-escalation/expansion study evaluated isatuximab (anti-CD38 monoclonal antibody) monotherapy in patients with relapsed/refractory multiple myeloma (RRMM). Patients progressing on or after standard therapy ...